Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update

被引:76
|
作者
Lin, Yiping [1 ]
Li, Yuke [1 ]
Zeng, Yuanlian [1 ]
Tian, Bin [1 ]
Qu, Xiaolan [1 ]
Yuan, Qianghua [2 ]
Song, Ying [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Affiliated Hosp, Chengdu, Peoples R China
关键词
magnolol; pharmacology; toxicity; bioavailability; formulation; NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; INDUCED INFLAMMATORY RESPONSE; NATURAL-PRODUCTS MAGNOLOL; STIMULATE GLUCOSE-UPTAKE; IN-VITRO; CANCER-CELLS; SIGNALING PATHWAY; OXIDATIVE STRESS; PPAR-GAMMA;
D O I
10.3389/fphar.2021.632767
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability
    Lee, Bong Sang
    Kang, Myung Joo
    Choi, Woo Sik
    Choi, Yoon Bae
    Kim, Hyung Soo
    Lee, Sang Kil
    Lee, Jaehwi
    Choi, Young Wook
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (11) : 1629 - 1635
  • [42] Vanadium bioavailability and toxicity to soil microorganisms and plants
    Larsson, Maja A.
    Baken, Stijn
    Gustafsson, Jon Petter
    Hadialhejazi, Golshid
    Smolders, Erik
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2013, 32 (10) : 2266 - 2273
  • [43] Adsorption, Bioavailability, and Toxicity of Cadmium to Soil Microorganisms
    Choi, Jaeyoung
    GEOMICROBIOLOGY JOURNAL, 2009, 26 (04) : 248 - 255
  • [44] Improved nasal bioavailability of elcatonin by insoluble powder formulation
    Ishikawa, F
    Katsura, M
    Tamai, I
    Tsuji, A
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 224 (1-2) : 105 - 114
  • [45] Distribution, speciation, toxicity and bioavailability of antimony in the environment
    He, MC
    Wan, HY
    PROGRESS IN CHEMISTRY, 2004, 16 (01) : 131 - 135
  • [46] Rifampicin and bioavailability in combination formulation
    Sosa, M.
    Szeliga, M. E.
    Fernandez, A.
    Bregni, C.
    ARS PHARMACEUTICA, 2005, 46 (04) : 353 - 364
  • [47] A systematic review of traditional uses, phytochemistry, pharmacology and toxicity of Epimedium koreanum Nakai
    Qian, Hui-qin
    Wu, Dou-can
    Li, Chun-yan
    Liu, Xin-ran
    Han, Xin-ke
    Peng, Yuan
    Zhang, Han
    Zhao, Bing-yan
    Zhao, Yuan
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318
  • [48] Xanthotoxin (8-methoxypsoralen): A review of its chemistry, pharmacology, pharmacokinetics, and toxicity
    Wu, Anxin
    Lu, Jing
    Zhong, Guofeng
    Lu, Ling
    Qu, Yan
    Zhang, Chen
    PHYTOTHERAPY RESEARCH, 2022, 36 (10) : 3805 - 3832
  • [49] In Vitro Skin Models and Their Predictability in Defining Normal and Disease Biology, Pharmacology, and Toxicity
    Danilenko, Dimitry M.
    Phillips, Gail D. Lewis
    Diaz, Dolores
    TOXICOLOGIC PATHOLOGY, 2016, 44 (04) : 555 - 563
  • [50] Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives
    Hayes, Micaela
    Ferruzzi, Mario G.
    NUTRITION RESEARCH, 2020, 81 : 19 - 37